For the Inventor, By the Inventor

Enter inventor name

Berlin, Germany

Burghardt Wittig

USPTO Granted Patents = 13 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 177(Granted Patents)

Company Filing History:

Mologen Forschungs Entwicklungs Und Vertriebs Gmbh

Years Active: 2002-2019

Loading Chart...

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10280424 - Covalently closed non-coding immunomodulatory DNA construct (2019-05-07),

2. 10006032 - Predictive biomarker for cancer therapy (2018-06-26),

3. 9499815 - Multimer for immunostimulation (2016-11-22),

4. 9345754 - Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine (2016-05-24),

5. 9212366 - Immune modulating oligonucleotides in connection with chemotherapeutic measures (2015-12-15),

6. 8669100 - [object Object] (2014-03-11),

7. 8017591 - Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals (2011-09-13),

8. 7795406 - Agent for treating leishmania infections (2010-09-14),

9. 7635468 - Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine (2009-12-22),

10. 7074772 - Design principle for the construction of expression constructs for gene therapy (2006-07-11),

11. 6849725 - Covalently closed nucleic acid molecules for immunostimulation (2005-02-01),

12. 6451593 - Design principle for construction of expression constructs for gene therapy (2002-09-17),

13. 6451563 - Method for making linear, covalently closed DNA constructs (2002-09-17),

Title: Burghardt Wittig: Innovator in Immunomodulatory DNA Constructs

Introduction

Burghardt Wittig is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of innovative DNA constructs for immunomodulation. With a total of 13 patents to his name, Wittig's work has the potential to impact cancer therapy and vaccine development.

Latest Patents

Wittig's latest patents include a covalently closed non-coding immunomodulatory DNA construct. This invention relates to a pharmaceutical composition and a vaccine designed for the modulation of the immune system. It provides a DNA construct for immunomodulation that comprises a specific DNA sequence. Another notable patent is a predictive biomarker for cancer therapy, which focuses on identifying patients suffering from cancer who are likely to respond to specific therapies. This invention particularly relates to a method for identifying responders to therapy using TLR-9 agonists.

Career Highlights

Throughout his career, Wittig has worked with several companies, including Mologen AG and Mologen Forschungs Entwicklungs Und Vertriebs GmbH. His work in these organizations has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Wittig has collaborated with notable colleagues such as Matthias Schroff and Manuel Schmidt. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Burghardt Wittig is a distinguished inventor whose work in immunomodulatory DNA constructs and cancer therapy has the potential to revolutionize medical treatments. His contributions to biotechnology continue to pave the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…